NeuroBo Pharmaceuticals, Inc. (NRBO)
NASDAQ: NRBO · Real-Time Price · USD
2.860
+0.010 (0.35%)
Oct 29, 2024, 4:00 PM EDT - Market closed
NeuroBo Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Oct '24 Oct 29, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 24 | 18 | 14 | 32 | 86 | 9,492 | |
Market Cap Growth | 233.87% | 31.75% | -58.04% | -62.38% | -99.09% | - | |
Enterprise Value | -4 | -8 | 7 | 26 | 74 | 9,508 | |
Last Close Price | 2.86 | 3.70 | 5.74 | 292.80 | 1260.00 | 2100.00 | |
PE Ratio | - | -1.50 | -0.13 | -1.85 | -2.87 | -2.14 | |
PB Ratio | 1.24 | 1.07 | 0.63 | 2.22 | 11.97 | 772.21 | |
P/FCF Ratio | -1.99 | -1.65 | -1.16 | -2.14 | -8.01 | -1308.70 | |
P/OCF Ratio | -2.00 | -1.66 | -1.16 | -2.14 | -8.01 | -1348.49 | |
EV/EBITDA Ratio | -0.90 | 0.48 | -0.64 | -1.67 | -6.00 | -1187.37 | |
EV/EBIT Ratio | -0.90 | 0.48 | -0.64 | -1.67 | -5.98 | -1184.86 | |
EV/FCF Ratio | -1.20 | 0.71 | -0.62 | -1.69 | -6.87 | -1310.97 | |
Debt / Equity Ratio | 0.01 | 0.01 | - | 0.00 | 0.01 | 0.01 | |
Debt / FCF Ratio | -0.01 | -0.02 | - | 0.00 | -0.01 | -0.02 | |
Quick Ratio | 2.89 | 3.76 | 2.83 | 7.60 | 2.73 | 6.68 | |
Current Ratio | 2.94 | 3.78 | 2.85 | 7.69 | 2.89 | 6.78 | |
Return on Equity (ROE) | -117.35% | -64.89% | -76.85% | -140.22% | -304.47% | -270.59% | |
Return on Assets (ROA) | -57.23% | -35.26% | -28.36% | -68.87% | -60.82% | -54.85% | |
Return on Capital (ROIC) | -74.83% | -51.39% | -39.19% | -87.06% | -78.51% | -62.66% | |
Earnings Yield | -106.70% | -69.53% | -102.60% | -47.11% | -34.41% | -0.22% | |
FCF Yield | -82.21% | -60.49% | -86.04% | -46.66% | -12.49% | -0.08% | |
Buyback Yield / Dilution | -84.99% | -1476.33% | -233.62% | -42.70% | -210.43% | -22.88% | |
Total Shareholder Return | -84.99% | -1476.33% | -233.62% | -42.70% | -210.43% | -22.88% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.